104 results on '"Kristensen, L.E."'
Search Results
2. Who are likely to benefit from the Good Life with osteoArthritis in Denmark (GLAD) exercise and education program? An effect modifier analysis of a randomised controlled trial
3. PCR229 Achieving Increasingly Stringent Disease Control Criteria Was Associated with Greater Quality of Life Improvements in Patients with Active Psoriatic Arthritis: Results from BE OPTIMAL and BE COMPLETE/BE VITAL up to 1 Year
4. Étude observationnelle prospective de 24 mois de la persistance du traitement chez des patients atteints de rhumatisme psoriasique (PRO-SPIRIT) – conception de l’étude et caractéristiques des patients à l’inclusion (échantillon complet)
5. Améliorations cliniquement significatives des critères-patient sous guselkumab chez les patients atteints de rhumatisme psoriasique actif en réponse inadéquate aux anti-TNF : résultats à un an d’une étude de phase 3b, randomisée, contrôlée (COSMOS)
6. Far-infrared line emission from the outer Galaxy cluster Gy 3-7 with SOFIA/FIFI-LS: Physical conditions and UV fields
7. An Ice Age JWST inventory of dense molecular cloud ices
8. L’atteinte de critères cliniques plus stricts est associée à de plus importantes améliorations des critères patients (fonction physique, douleur) chez les patients atteints de rhumatisme psoriasique actif : résultats à 16 semaines de 2 études de phase III
9. Le bimékizumab améliore la qualité de vie chez les patients atteints de rhumatisme psoriasique actif, naïfs de biologiques ou avec réponse inadéquate aux anti-TNF : résultats à 16 semaines de 2 études de phase III randomisées, contrôlées par placebo
10. Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial
11. The effect of risankizumab on achieving minimal clinically important differences in patient‐reported outcomes in patients with psoriatic arthritis: results from KEEPsAKE 1 and 2
12. Hypoglycaemia and QT interval prolongation in type 1 diabetes – bridging the gap between clamp studies and spontaneous episodes
13. The effect of risankizumab on achieving minimal clinically important differences in patient‐reported outcomes in patients with psoriatic arthritis:results from KEEPsAKE 1 and 2
14. Effects of risankizumab on nail psoriasis in patients with active psoriatic arthritis: results from KEEPsAKE 1
15. A pilot study examining patient preference and satisfaction for ava®, a reusable electronic injection device to administer certolizumab pegol
16. Translation and cultural adaptation of the intermittent and constant osteoarthritis pain (ICOAP) knee questionnaire into Danish
17. PMD60 AN INNOVATIVE REUSABLE ELECTRONIC INJECTION DEVICE FOR CERTOLIZUMAB PEGOL: RESULTS FROM A PILOT MARKET RESEARCH STUDY EXAMINING PATIENT PREFERENCE AND SATISFACTION
18. Rapid and sustained health utility gain in anti-tumour necrosis factor-treated inflammatory arthritis: observational data during 7 years in southern Sweden
19. Efficacy and tolerability of anti-tumour necrosis factor in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register
20. Added value of combining methotrexate with a biological agent compared to biological monotherapy in rheumatoid arthritis patients:A systematic review and meta-analysis of randomised trials
21. A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience
22. Gout is associated with an increased risk of cancer –: a nationwide cohort study including over 70,000 gout patients
23. 改善:银屑病和银屑病关节炎中的死亡率
24. IMPROVE: mortality in psoriasis and psoriatic arthritis
25. Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
26. Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
27. THU0316 Gender differences in biologic treatment outcomes – a study of 1750 patients with psoriatic arthritis using danish health care registers
28. SAT0081 Changes in incidence of shoulder, elbow, wrist and finger replacement surgery among rheumatoid arthritis patients following the introduction of biological dmards: an interrupted time series analysis using danish health care registers
29. Luminous, pc-scale CO 6-5 emission in the obscured nucleus of NGC 1377
30. Cause‐specific mortality in patients with psoriasis and psoriatic arthritis
31. SAT0081 Changes in incidence of shoulder, elbow, wrist and finger replacement surgery among rheumatoid arthritis patients following the introduction of biological dmards: an interrupted time series analysis using danish health care registers
32. THU0284 Haq in psoriatic arthritis is driven by gender, inflammation and ageing: observational data from cohort studies in uk, denmark, iceland and sweden
33. SAT0365 Secular trends in the incidence and prevalence of gout in denmark from 1995–2015: a nationwide register-based study
34. THU0316 Gender differences in biologic treatment outcomes – a study of 1750 patients with psoriatic arthritis using danish health care registers
35. THU0332 Fatigue remains a dominatng symptom despite tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study
36. THU0313 Ixekizumab improves nail and skin lesions through 52 weeks in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors
37. SAT0303 Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: results of a danish prospective, exploratory cohort study
38. A precessing molecular jet signaling an obscured, growing supermassive black hole in NGC 1377?
39. Cause‐specific mortality in patients with psoriasis and psoriatic arthritis.
40. THU0418 Obesity Impairs The Response To Tumour Necrosis Factor-Alpha Inhibitors in Psoriatic Arthritis: Results from The DANBIO and ICEBIO Registries
41. SAT0619 Relationship between HAQ Disability Scores and Measures of Observed Functional Ability in Patents with Rheumatoid Arthritis, Ostearthritis and fibromyalgia and The Association To Pain and Fatigue
42. SAT0369 EQ-5D Utility, Response and Drug Adherence in Rheumatoid Arthritis Patients on Biologic Monotherapy: A Prospective Observational Study of Patients Registered in the South Swedish SSATG Registry
43. OP0275 Birth Characteristics and Childhood Infections Predict Ankylosing Spondylitis. A National Register Based Nested Case-Control Study
44. AB1084 Correlations Between Different Imaging Modalities in the Assessment of Acute Synovitis of the Wrist in Rheumatoid Arthritis: A Cross-Sectional Study: Table 1.
45. SAT0200 Adherence to Therapy of Rituximab in Clinical Practice. NO Relation to Initial or Cumulative Dose Over the First 2 Treatment Years
46. THU0305 Fatigue is Correlated to Pain Mechanism Rather than to Inflammatory Load in Patients with Rheumatoid Arthritis: A Descriptive Cross-Sectional Danbio Registry Survey
47. OP0289 Comorbidity with Depression and Anxiety is Associated with Discontinuation of Tumour Necrosis Factor Inhibitor (TNFI) Therapy in Ankylosing Spondylitis (AS)
48. THU0326 Pain Mechanisms in Patients with Inflammatory Arthritis: A Nationwide Cross-Sectional Danbio Registry Survey
49. THU0597 Work Disability in Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis Before and After Start of Anti-Tnf Therapy: A Swedish Observational Study
50. Observational 2D model of H-2 emission from bow shock in the Orion Molecular Cloud
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.